JPWO2022133148A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022133148A5 JPWO2022133148A5 JP2023537184A JP2023537184A JPWO2022133148A5 JP WO2022133148 A5 JPWO2022133148 A5 JP WO2022133148A5 JP 2023537184 A JP2023537184 A JP 2023537184A JP 2023537184 A JP2023537184 A JP 2023537184A JP WO2022133148 A5 JPWO2022133148 A5 JP WO2022133148A5
- Authority
- JP
- Japan
- Prior art keywords
- pharma
- acceptable salt
- isolated polypeptide
- ceutically acceptable
- positions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063126736P | 2020-12-17 | 2020-12-17 | |
| US63/126,736 | 2020-12-17 | ||
| PCT/US2021/063920 WO2022133148A1 (en) | 2020-12-17 | 2021-12-16 | Long acting glucagon like polypeptide-1 (glp-1) receptor agonists and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024502740A JP2024502740A (ja) | 2024-01-23 |
| JPWO2022133148A5 true JPWO2022133148A5 (https=) | 2024-12-23 |
| JP2024502740A5 JP2024502740A5 (https=) | 2024-12-23 |
Family
ID=80123475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023537184A Pending JP2024502740A (ja) | 2020-12-17 | 2021-12-16 | 長時間作用型グルカゴン様ポリペプチド－１（ｇｌｐ－１）受容体アゴニスト及び使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US12084485B2 (https=) |
| EP (1) | EP4263587A1 (https=) |
| JP (1) | JP2024502740A (https=) |
| KR (1) | KR20230156689A (https=) |
| CN (1) | CN116917311A (https=) |
| AR (1) | AR124395A1 (https=) |
| AU (1) | AU2021400738A1 (https=) |
| CA (1) | CA3202389A1 (https=) |
| IL (1) | IL303686A (https=) |
| MX (1) | MX2023007224A (https=) |
| TW (1) | TW202237628A (https=) |
| WO (1) | WO2022133148A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022159395A1 (en) | 2021-01-20 | 2022-07-28 | Viking Therapeutics, Inc. | Compositions and methods for the treatment of metabolic and liver disorders |
| MX2024003236A (es) | 2021-09-15 | 2024-06-19 | Viking Therapeutics Inc | Composiciones y metodos para el tratamiento de trastornos metabolicos y hepaticos. |
| AU2024218747A1 (en) * | 2023-02-10 | 2025-08-28 | Hangzhou Sciwind Biosciences Co., Ltd. | Polypeptide and derivative thereof, composition, and use thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100256056A1 (en) | 2007-09-07 | 2010-10-07 | Zheng Xin Dong | Analogues of exendin-4 and exendin-3 |
| SMT201700583T1 (it) | 2009-09-28 | 2018-01-11 | Intarcia Therapeutics Inc | Instaurazione e/o terminazione rapida di erogazione di farmaci in modo sostanzialmente stazionario |
| JP6165168B2 (ja) * | 2011-12-22 | 2017-07-19 | ファイザー・インク | 抗糖尿病化合物 |
| UA116217C2 (uk) * | 2012-10-09 | 2018-02-26 | Санофі | Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону |
| RU2760007C2 (ru) * | 2016-05-16 | 2021-11-22 | Интарсия Терапьютикс, Инк. | Полипептиды, селективные к рецепторам глюкагона, и способы их применения |
| AU2017277594A1 (en) * | 2016-06-09 | 2019-02-07 | Medimmune Limited | Protease-resistant mono-lipidated peptides |
| CN111333714A (zh) | 2020-03-05 | 2020-06-26 | 成都奥达生物科技有限公司 | 一种长效glp-1化合物 |
-
2021
- 2021-12-16 AR ARP210103539A patent/AR124395A1/es unknown
- 2021-12-16 JP JP2023537184A patent/JP2024502740A/ja active Pending
- 2021-12-16 EP EP21851897.5A patent/EP4263587A1/en not_active Withdrawn
- 2021-12-16 CA CA3202389A patent/CA3202389A1/en active Pending
- 2021-12-16 KR KR1020237023789A patent/KR20230156689A/ko active Pending
- 2021-12-16 MX MX2023007224A patent/MX2023007224A/es unknown
- 2021-12-16 CN CN202180089098.0A patent/CN116917311A/zh active Pending
- 2021-12-16 US US17/553,381 patent/US12084485B2/en active Active
- 2021-12-16 IL IL303686A patent/IL303686A/en unknown
- 2021-12-16 WO PCT/US2021/063920 patent/WO2022133148A1/en not_active Ceased
- 2021-12-16 AU AU2021400738A patent/AU2021400738A1/en active Pending
- 2021-12-17 TW TW110147341A patent/TW202237628A/zh unknown
-
2024
- 2024-07-22 US US18/779,857 patent/US20250034225A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102434280B1 (ko) | 옥신토모듈린과 면역글로불린 단편을 포함하는 단백질 결합체의 액상 제제 | |
| JP2023078367A (ja) | 新規ｇｌｐ－１類似体 | |
| CN108136043B (zh) | 蛋白质缀合物 | |
| RU2008141280A (ru) | Агонисты рецептора нейромедина u и их применение | |
| TWI618697B (zh) | 化合物、連接子－藥物、及配體－藥物耦合體 | |
| JP2023541798A (ja) | Ｃｒｆ２受容体アゴニスト及び治療におけるその使用 | |
| WO2019207427A2 (en) | Thioether cyclic peptide amylin receptor modulators | |
| JPWO2022133148A5 (https=) | ||
| AU2021275541A1 (en) | Liquid formulation of long-acting conjugate of GLP-2 | |
| JPWO2021066600A5 (https=) | ||
| IL299778A (en) | Therapeutic use of glucagon derivative or conjugate thereof for liver disease | |
| AU2024317572A1 (en) | Antibody conjugates and fusion proteins | |
| JPWO2022068920A5 (https=) | ||
| JP2002522355A5 (https=) | ||
| EP4302776A1 (en) | Combination therapy of insulinotropic peptide and glp-2, for preventing or treating short bowel syndrome | |
| JP2026031900A (ja) | Ｆｃ－アシル化ポリペプチドコンジュゲート | |
| JPWO2020065408A5 (https=) | ||
| JP2026040494A (ja) | Ｇｌｐ－２又はその結合体を含む、代謝性骨疾患の予防又は治療用薬学的組成物 | |
| JPWO2023164618A5 (https=) | ||
| CN119325387A (zh) | 用于预防或治疗肠病的GLP-2与促胰岛素肽、TNFα抑制剂或两者的组合疗法 | |
| CN119868576A (zh) | 用于制备抗体与药物偶联物的中间体及其制备方法和应用 | |
| CN115776880A (zh) | 液体制剂 | |
| HK40111230A (zh) | 用於靶向细胞表面受体的可裂解放射性配体及其用途 | |
| HK40023221B (en) | Liquid formulation of protein conjugate comprising the oxyntomodulin and an immunoglobulin fragment | |
| HK40023221A (en) | Liquid formulation of protein conjugate comprising the oxyntomodulin and an immunoglobulin fragment |